Tirsa L.E. van Westering

ORCID: 0000-0003-0278-1245
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Muscle Physiology and Disorders
  • Adipose Tissue and Metabolism
  • Cardiomyopathy and Myosin Studies
  • Mitochondrial Function and Pathology
  • Neurogenetic and Muscular Disorders Research
  • Silk-based biomaterials and applications
  • Sirtuins and Resveratrol in Medicine
  • Genetic Neurodegenerative Diseases
  • Circadian rhythm and melatonin
  • Microgrid Control and Optimization
  • Congenital Anomalies and Fetal Surgery
  • Energy Harvesting in Wireless Networks
  • Photoreceptor and optogenetics research
  • Muscle metabolism and nutrition
  • Electrospun Nanofibers in Biomedical Applications
  • RNA Research and Splicing
  • Sleep and Wakefulness Research
  • RNA modifications and cancer
  • Kruppel-like factors research

University of Oxford
2015-2020

Leiden University Medical Center
2014

Significance The inhibitory neurotransmitter GABA plays an important role in many brain circuits involved anxiety, depression, epilepsy, and sleep disorders. is critical for maintaining the balance between excitatory transmission, thereby ensuring proper neuronal network function. Here, we report that entraining mice to a long-day photoperiod can modify excitatory/inhibitory suprachiasmatic by increasing GABAergic excitation. These data suggest day length affects of circadian clock. This...

10.1073/pnas.1319820111 article EN Proceedings of the National Academy of Sciences 2014-06-16

The circadian glucocorticoid-Krüppel-like factor 15-branched-chain amino acid (GC-KLF15-BCAA) signaling pathway is a key regulatory axis in muscle, whose imbalance has wide-reaching effects on metabolic homeostasis. Spinal muscular atrophy (SMA) neuromuscular disorder also characterized by intrinsic muscle pathologies, abnormalities and disrupted sleep patterns, which can influence or be influenced networks that control behavioral rhythms. We therefore set out to investigate the contribution...

10.1016/j.ebiom.2018.04.024 article EN cc-by EBioMedicine 2018-05-01

The absence of the dystrophin protein in Duchenne muscular dystrophy (DMD) results myofiber fragility and a plethora downstream secondary pathologies. Although variety experimental therapies are development, achieving effective treatments for DMD remains exceptionally challenging, not least because pathological consequences loss incompletely understood. Here we have performed proteome profiling tibialis anterior muscles from two murine models (

10.1074/mcp.ra120.002345 article EN cc-by Molecular & Cellular Proteomics 2020-09-29

Abstract Background Duchenne muscular dystrophy (DMD) is a fatal muscle‐wasting disorder caused by genetic loss of dystrophin protein. Extracellular microRNAs (ex‐miRNAs) are putative, minimally invasive biomarkers DMD. Specific ex‐miRNAs (e.g. miR‐1, miR‐133a, miR‐206, and miR‐483) highly up‐regulated in the serum DMD patients dystrophic animal models restored to wild‐type levels following exon skipping‐mediated rescue mdx mice. As such, promising pharmacodynamic skipping efficacy. Here, we...

10.1002/jcsm.12506 article EN cc-by Journal of Cachexia Sarcopenia and Muscle 2019-12-17

Physiology and behaviour are critically dependent on circadian regulation via a core set of clock genes, dysregulation which leads to metabolic sleep disturbances. Metabolic perturbations occur in spinal muscular atrophy (SMA), neuromuscular disorder caused by loss the survival motor neuron (SMN) protein characterized muscle atrophy. We therefore investigated expression rhythm genes various tissues cord Taiwanese Smn-/-;SMN2 SMA animal model. demonstrate dysregulated (clock, ARNTL/Bmal1,...

10.1093/hmg/ddy249 article EN cc-by Human Molecular Genetics 2018-07-04

Duchenne muscular dystrophy (DMD) is caused by loss of dystrophin protein, leading to progressive muscle weakness and premature death due respiratory and/or cardiac complications. Cardiac involvement characterized dilated cardiomyopathy, decreased fractional shortening metabolic dysfunction involving reduced metabolism fatty acids-the major substrate. Several mouse models have been developed study molecular pathological consequences deficiency, but do not recapitulate all aspects human...

10.1093/hmg/ddy346 article EN cc-by Human Molecular Genetics 2018-10-01
Coming Soon ...